Get short URL © Jim Bourg / Reuters In another attempt at quelling public outcry over the skyrocketing price of the lifesaving EpiPen, maker Mylan has announced that it will begin selling a generic version of its allergy medication injector ‒ at the low, low cost of $300. EpiPen administers a quick dose of epinephrine to counter a severe, life-threatening allergic reaction known as anaphylactic shock. The easy-to-use injector is made by West Virginia-based Mylan Pharmaceuticals, which bought the rights to it in 2007. Since then, the price of the EpiPen has ballooned, going from $100 to $600. On Monday, Mylan unveiled the generic version, noting that the auto-injector’s “list price of $300” for each two-pack carton “represents a discount of more than 50 percent to the Mylan list price.” Monopoly & lobbyists: Research reveals why US drugs are so pricey "We understand the deep frustration and concerns associated with the cost of EpiPen to the patient, and have always shared the public's desire to ensure that this important product be accessible to anyone who needs it,” CEO Heather Bresch said in a statement . “Our decision to launch a generic alternative to EpiPen is an extraordinary commercial response.” The generic version will be identical to the branded one ‒ at both the 0.15-mg and 0.30-mg dosages ‒ and will be launched in “several weeks,” after the company completes labeling revisions. The announcement comes just four days after Mylan’s last public relations stunt, when the company said it would [...]